Skip to content
Dose Brief
Menu

Evidence & access

GLP-1 shipment arrived warm: what to do next

Document the delivery, contact the dispensing pharmacy and follow product-specific advice. Do not assume one GLP-1 storage rule fits every shipment.

By The Dose Brief Desk, News Editor

Updated · Editorial standards

In this brief

If an injectable GLP-1 arrives warm or without adequate refrigeration, do not use it while you seek help. FDA specifically advises against using injectable GLP-1 drugs that arrive warm or insufficiently refrigerated because quality may be affected.1 Contact the dispensing pharmacy and your prescriber for a replacement or next-step plan.

Start with the actual product

Read the medication and pharmacy labels rather than relying on the provider's logo. Record the drug name, formulation, strength, prescription number, lot if shown and dispensing pharmacy. The exact product matters when someone assesses a shipping problem.

A branded pen, an unopened compounded vial and a vial already in use are different situations. Do not borrow a storage allowance from an online discussion about another product. Our injection and storage guide provides background, but the pharmacist needs to assess the medication you received.

Make a delivery record before discarding packaging

Note when the carrier marked the package delivered and when you opened it. Photograph the outer box, insulation, ice packs and medication label. Record any broken packaging, leakage or temperature indicator reading. If you did not measure a temperature, say it felt warm rather than assigning a number.

These are practical documentation steps, not a home quality test. A photograph cannot establish potency or sterility. Its value is helping the pharmacy reconstruct what happened and identify the shipment without repeated requests for basic details.

Contact the pharmacy through the phone number on the dispensing label or a verified contact channel. If the telehealth platform handles replacements, notify it as well. Keep the medication out of use and ask the pharmacist how to store it pending assessment. Do not attempt to rescue a questionable shipment by freezing it or changing the dose.

Questions for the pharmacist

Ask: “This shipment arrived at [time] and I opened it at [time]. The package was [describe what you observed]. Can you assess this exact product and shipment? Should it be replaced, and how should I handle the medication while you arrange that?” Share photos through the channel the pharmacy requests.

If the response is simply that the medication is fine, ask what product-specific information supports that answer. Request written instructions, a case number and the person's name. If you are told to discard it, ask for safe disposal instructions and confirmation of the replacement arrangements.

Handle the next scheduled dose separately

Tell your prescriber if the shipping problem could interrupt treatment. Ask for instructions appropriate to your medication and the timing of your last dose. Do not double a later dose, use a different person's medication or substitute a product from another supplier on your own.

For a patient, the practical problem has two parts: whether this shipment can be used and how to avoid an unmanaged gap in care. A customer-service refund resolves the payment issue; it does not answer the prescribing question. Keep both requests open until the appropriate person has responded.

A cold pack is not a complete answer

A melted ice pack does not tell you the medication's entire temperature history. Nor does a cool box by itself settle every question about shipping conditions. Describe what you can observe and leave the product assessment to the dispensing pharmacist. There is no universal number of hours this article can safely apply across all GLP-1 formulations and shipment conditions.

Compounded drugs are not FDA-approved, and a compounded preparation should not be assumed equivalent to a branded product.2 If you cannot identify who dispensed your prescription, use our pharmacy verification guide and ask the provider directly.

Reporting a quality problem

FDA accepts reports of medication quality problems and adverse events through MedWatch.1 Reporting a concern does not replace getting care, contacting the pharmacy or arranging your next dose. If you become seriously unwell, seek urgent medical help rather than waiting for a shipping ticket to be answered.

Keep the shipping record, pharmacy response and replacement tracking together. For a recurring delivery problem, ask whether another delivery arrangement is available before the next shipment leaves.

Frequently asked questions

Can I use a GLP-1 injection that arrived warm?

FDA advises against using injectable GLP-1 drugs that arrive warm or insufficiently refrigerated. Contact the dispensing pharmacist and prescriber for next steps.

Does a melted ice pack prove the medication is spoiled?

It does not establish the full temperature history. Document the shipment and ask the pharmacist to assess the exact product; do not decide based on the ice pack alone.

References

  1. U.S. Food and Drug Administration (2026). FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. FDA (accessed October 6, 2026; year shown is access year, not publication year). https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
  2. U.S. Food and Drug Administration (2026). Compounding and the FDA: Questions and Answers. FDA (accessed October 6, 2026; year shown is access year, not publication year). https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.